# Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting

Study · id `cardio:ct-nct01159639` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01159639](<https://clinicaltrials.gov/study/NCT01159639>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01159639

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT01159639. Randomized; no masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2013-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT01159639, source copy `cardio:ctgov-nct01159639-2013-08-28`, retrieved 2026-10-26)
- Start date: 2010-06 (registry gives no type) (ClinicalTrials.gov record NCT01159639, source copy `cardio:ctgov-nct01159639-2013-08-28`, retrieved 2026-10-26)
- Primary completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01159639, source copy `cardio:ctgov-nct01159639-2013-08-28`, retrieved 2026-10-26)
- Completion: 2013-02 (actual) (ClinicalTrials.gov record NCT01159639, source copy `cardio:ctgov-nct01159639-2013-08-28`, retrieved 2026-10-26)
- Countries: Croatia (ClinicalTrials.gov record NCT01159639, source copy `cardio:ctgov-nct01159639-2013-08-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01159639-2013-08-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
- Condition: Coronary Artery Disease
- Condition: Aspirin Resistance
- Intervention (Drug): Clopidogrel
- Lead sponsor: University of Zagreb
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: University of Zagreb (`cardio:org-university-of-zagreb`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting (`cardio:pubmed-24666617`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639) (`cardio:pubmed-25095738`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Postoperative Atrial Fibrillation Is Associated With High On-Aspirin Platelet Reactivity (`cardio:pubmed-26215778`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c983e0669d1148b83da6b166de03dbdf23c57b63e78e513292c8068cf900872b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
